Literature DB >> 1095522

The primary antibacterial defense mechanism of the bladder.

C L Parsons, C Greenspan, S G Mulholland.   

Abstract

We have developed a model in rabbits for quantitatively determining the attachment of microbial organisms to the vesical mucosa. Our data suggest that the bladder has a primary antibacterial defense mechanism that serves to interrupt microbial attachment. This mechanism seems to be secretory, since after destruction with acid, the resistance to microbial binding returns in less than 24 hr.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1095522

Source DB:  PubMed          Journal:  Invest Urol        ISSN： 0021-0005


  28 in total

1.  Adherence of bacterial to vaginal epithelial cells.

Authors:  P A Mårdh; L Westtöm
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

Review 2.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

3.  Treatment of mice with staphylococcal enterotoxin B enhances resolution of an induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines.

Authors:  M D Morin; W J Hopkins
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Bladder surface mucin. Its antibacterial effect against various bacterial species.

Authors:  C L Parsons; S G Mulholland
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 5.  Urinary infections in adults--1985.

Authors:  W R Cattell
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

6.  Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate).

Authors:  C L Parsons; J J Pollen; H Anwar; C Stauffer; J D Schmidt
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

7.  Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate.

Authors:  C L Parsons; C W Stauffer; J D Schmidt
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

8.  Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey.

Authors:  Antonio Cicione; Francesco Cantiello; Giuseppe Ucciero; Andrea Salonia; Marco Torella; Marco De Sio; Riccardo Autorino; Antonio Carbone; Martin Romancik; Roman Tomaskin; Rocco Damiano
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

9.  The effects of heparin on the adherence of five species of urinary tract pathogens to urinary bladder mucosa.

Authors:  M R Ruggieri; P M Hanno; R M Levin
Journal:  Urol Res       Date:  1984

10.  Influence of urological irrigation fluids on urothelial bacterial adherence.

Authors:  T C Gasser; P O Madsen
Journal:  Urol Res       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.